When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Síndrome do olho seco

Last reviewed: 3 Feb 2026
Last updated: 19 Jun 2025

Summary

Definition

History and exam

Key diagnostic factors

  • causa clínica subjacente conhecida
  • uso de medicamentos causadores conhecidos
  • filamentos corneanos
Full details

Other diagnostic factors

  • irritação ocular/sensação de corpo estranho
  • ardência ocular
  • visão turva transitória
  • lacrimejamento
  • blefarite/meibomianite
  • erosões epiteliais pontuadas
  • erosões conjuntivais ponteadas
  • hiperemia conjuntival
  • lagoftalmia
  • proptose
  • presença de ácaros
Full details

Risk factors

  • sexo feminino
  • idade avançada
  • blefarite/meibomianite
  • doenças do tecido conjuntivo
  • deficiência de vitamina A
  • hepatite C
  • vírus da imunodeficiência humana (HIV)
  • transplante de células-tronco hematopoéticas
  • cirurgia do cristalino e das pálpebras
  • uso de lentes de contato
  • diabetes mellitus
  • medicamentos sistêmicos
  • medicamentos oftálmicos tópicos preservados
  • sarcoidose
  • Doença de Parkinson
  • fatores ambientais
  • fatores ocupacionais
  • cefaleia
Full details

Diagnostic tests

1st tests to order

  • altura do menisco do filme lacrimal (meniscometria)
  • tempo de ruptura do filme lacrimal/fluoresceína (TRFL)
  • teste de Schirmer
Full details

Emerging tests

  • osmometria do filme lacrimal
  • detecção da metaloproteinase-9 (MMP-9)
  • topografia corneana
  • interferometria da superfície ocular
  • termografia infravermelha
  • microscopia confocal in vivo
  • marcadores imunes da superfície ocular (OSIM)

Treatment algorithm

ACUTE

olho seco na apresentação inicial

ONGOING

olho seco crônico

Contributors

Authors

Jonathan Smith, FRCOphth, MRCP

Consultant Ophthalmologist

Sunderland Eye Infirmary

Sunderland

UK

Disclosures

JS declares that he has no competing interests.

Philip Severn, FRCOphth, MRCP

Consultant Ophthalmologist

James Cook University Hospital

Middlesbrough

UK

Disclosures

PS declares that he has served on the advisory boards of and received travel grants from Bayer and Novartis. He has also received travel grants from Allergan.

Darren Shu Jeng Ting, FRCOphth, PhD

Honorary Associate Professor of Ophthalmology

School of Medicine

University of Nottingham

Consultant Ophthalmologist

Birmingham and Midland Eye Centre

UK

Disclosures

DSJT declares that he has no competing interests.

Saurabh Ghosh, FRCOphth

Consultant Ophthalmologist

Sunderland Eye Infirmary

Sunderland

UK

Disclosures

SG declares that he has no competing interests.

Peer reviewers

I-Hui Wu, MD

Ophthalmology Resident

Wilmer Eye Institute

Baltimore

MD

Disclosures

IW declares that she has no competing interests.

Gus Gazzard, MA, MBBChir, MD, FRCOphth

Consultant Ophthalmic Surgeon

King's College Hospital

Honorary Research Fellow

Institute of Ophthalmology

London

UK

Disclosures

GG declares that he has no competing interests.

Bob Avery, MD, PhD

Assistant Professor

Ophthalmology

University of New Mexico Medical School

Albuquerque

NM

Disclosures

BA declares that he has no competing interests.

Vatinee Y. Bunya, MD

Co-Director

Penn Dry Eye and Ocular Surface Center

Assistant Professor

Cornea and External Disease

Scheie Eye Institute

Philadelphia

PA

Disclosures

VYB declares that she has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Hakim FE, Farooq AV. Dry eye disease: an update in 2022. JAMA. 2022 Feb 1;327(5):478-9. Abstract

Amescua G, Ahmad S, Cheung AY, et al. Dry eye syndrome preferred practice pattern®. Ophthalmology. 2024 Apr;131(4):P1-49.Full text  Abstract

Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017 Jul;15(3):276-83.Full text  Abstract

Shtein RM, Shen JF, Kuo AN, et al. Autologous serum-based eye drops for treatment of ocular surface disease: a report by the American Academy of Ophthalmology. Ophthalmology. 2020 Jan;127(1):128-33.Full text  Abstract

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Síndrome do olho seco images
  • Differentials

    • Olho vermelho
    • Síndrome de Sjögren
    • Disfunção das glândulas meibomianas
    More Differentials
  • Guidelines

    • Dry eye syndrome preferred practice pattern
    • Cornea/external disease summary benchmarks - 2024
    More Guidelines
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer